RLX
RLX Technology, Inc.
NYSE · Consumer Defensive · Tobacco · CN
$1.68
+0.00%Year over year
Reported trailing growth
- Revenue
- +53.3%
- EBITDA
- +133.7%
- EBIT
- +519.7%
- EPS
- +34.7%
- Free cash flow
- -61.4%
- Operating cash flow
- -50.9%
Forward estimates
Based on analyst estimates
- Revenue
- -60.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.9%
- EBITDA
- -16.9%
- EBIT
- -33.0%
- Net income
- -14.6%
- EPS
- -13.7%
- Free cash flow
- +30.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026